In particular, inhibition of NAF-1 expression can enhance pancreatic cancer cell sensitivity to gemcitabine, demonstrating the function of NAF-1 in the chemoresistance of pancreatic cancer cells. The gene discussed is NAF1; the disease is familial pancreatic carcinoma.